Kepos Capital LP Ionis Pharmaceuticals Inc Call Options Transaction History
Kepos Capital LP
- $121 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IONS
# of Institutions
397Shares Held
134MCall Options Held
786KPut Options Held
747K-
Vanguard Group Inc Valley Forge, PA16.4MShares$551 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$477 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$416 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$347 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$283 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.78B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...